Of the 72 drugs in phase two of development as of July 2019, 13 were focused on inhibiting amyloid production in the brain in order to hinder the growth of plaques. This statistic depicts the number of Alzheimer's drugs in phase two of clinical trials, by mechanism of action.
Number of Alzheimer's drugs in phase 2 of clinical trials as of July 2019, by mechanism of action
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
BioSpace. (September 23, 2019). Number of Alzheimer's drugs in phase 2 of clinical trials as of July 2019, by mechanism of action [Graph]. In Statista. Retrieved August 25, 2024, from https://www.statista.com/statistics/1093314/alzheimers-phase-2-drugs-by-mechanism-of-action/
BioSpace. "Number of Alzheimer's drugs in phase 2 of clinical trials as of July 2019, by mechanism of action." Chart. September 23, 2019. Statista. Accessed August 25, 2024. https://www.statista.com/statistics/1093314/alzheimers-phase-2-drugs-by-mechanism-of-action/
BioSpace. (2019). Number of Alzheimer's drugs in phase 2 of clinical trials as of July 2019, by mechanism of action. Statista. Statista Inc.. Accessed: August 25, 2024. https://www.statista.com/statistics/1093314/alzheimers-phase-2-drugs-by-mechanism-of-action/
BioSpace. "Number of Alzheimer's Drugs in Phase 2 of Clinical Trials as of July 2019, by Mechanism of Action." Statista, Statista Inc., 23 Sep 2019, https://www.statista.com/statistics/1093314/alzheimers-phase-2-drugs-by-mechanism-of-action/
BioSpace, Number of Alzheimer's drugs in phase 2 of clinical trials as of July 2019, by mechanism of action Statista, https://www.statista.com/statistics/1093314/alzheimers-phase-2-drugs-by-mechanism-of-action/ (last visited August 25, 2024)
Number of Alzheimer's drugs in phase 2 of clinical trials as of July 2019, by mechanism of action [Graph], BioSpace, September 23, 2019. [Online]. Available: https://www.statista.com/statistics/1093314/alzheimers-phase-2-drugs-by-mechanism-of-action/